Patients

Preclinical Phase 1 Phase 2 Phase 3
Systemic Sclerosis
Preclinical Phase complete
Phase 1 Phase complete
Phase 2 Phase in progress
Phase 3 Phase not started
Cystic Fibrosis
Preclinical Phase complete
Phase 1 Phase complete
Phase 2 Phase in progress
Phase 3 Phase not started
Dermatomyositis
Preclinical Phase complete
Phase 1 Phase complete
Phase 2 Phase in progress
Phase 3 Phase not started
Systemic Lupus Erythematosus
Preclinical Phase complete
Phase 1 Phase complete
Phase 2 Phase in progress
Phase 3 Phase not started

Corbus is currently evaluating anabasum in three active Phase 2 clinical trials, cystic fibrosis, diffuse cutaneous systemic sclerosis (scleroderma) and dermatomyositis. To learn more about each of our ongoing studies, please select one of the above indications.